A Case of Avascular Necrosis of the Femoral Head as Initial Presentation of Chronic Myelogenous Leukemia

Ji‐Yong Moon(Hanyang University), Myung‐Ju Ahn(Sungkyunkwan University), Hye Ryeon Yun(Hanyang University), Jung Hye Choi(Hanyang University Guri Hospital), In Soon Kim(Hanyang University), Byung Su Kim(Armed Forces Capital Hospital), Young Yul Lee(Hanyang University)

The Korean Journal of Internal Medicine

January 1, 2005

10.3904/kjim.2005.20.3.255

Cited by 13

Related Papers

Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer

|New England Journal of Medicine|2013|3.4k

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

|The Lancet|2019|3.4k

Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer

|New England Journal of Medicine|2016|3.3k

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

|The Lancet|2018|1.7k

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials

|The Lancet Oncology|2019|537